Manipal Hospitals Eyes $1 Billion IPO in July with $10 Billion Valuation
Manipal Health Enterprises, the operator of India’s prominent Manipal Hospitals chain, is reportedly preparing to launch a massive initial public offering (IPO) as early as next month. Backed by Singapore’s Temasek Holdings, the healthcare giant is targeting a significant market valuation as it seeks to capitalize on the evolving healthcare landscape.
A Potential Milestone for Indian Equity Markets
If the proposed offering proceeds as planned, Manipal Hospitals could become India’s first billion-dollar IPO of the year. This move comes at a critical juncture for the Indian equity capital markets, which have experienced a relatively slow start to 2026 compared to the record-breaking performance seen in previous years. So far, Indian companies have raised approximately $3.6 billion through first-time share sales this year. A successful listing by Manipal could provide the necessary momentum to revitalize investor sentiment and drive large-scale capital inflows into the primary market.
Breakdown of the Offering and Valuation Targets
According to sources familiar with the matter, Manipal Health Enterprises is eyeing a valuation of approximately $10 billion. While specific details regarding the final size and exact timing remain subject to ongoing deliberations, the draft prospectus filed with India’s market regulator in March provides a clear roadmap of the company's intentions.
The proposed share sale is structured into two main components:
- Fresh Issue: A new issuance of shares worth approximately ₹80 billion to bolster the company's capital base.
- Secondary Offering: Existing investors are expected to sell up to 43.23 million shares, representing about a 3.66% stake in the company.
Global and Domestic Financial Heavyweights Involved
To ensure a seamless transition to the public markets, Manipal Hospitals has assembled a powerhouse group of financial advisers. The company is working with a blend of premier Indian institutions and global investment banks to manage the complex listing process.
The advisory lineup includes domestic leaders such as Kotak Mahindra Capital Co. and Axis Capital Ltd. On the international front, the company is leveraging the expertise of Goldman Sachs Group Inc., JPMorgan Chase & Co., Jefferies Financial Group Inc., UBS Securities, and DBS Bank Ltd. This high-profile roster underscores the global interest in India's private healthcare sector and the significant scale of the upcoming offering.
Key Takeaways
- Massive Valuation: Manipal Hospitals is targeting a $10 billion valuation, aiming to lead the charge for large-scale IPOs in 2026.
- Dual Offering Structure: The IPO will consist of an ₹80 billion fresh issue alongside a secondary sale of roughly 3.66% stake by existing investors.
- Market Catalyst: As a potential billion-dollar listing, the IPO is expected to act as a significant driver for momentum in the Indian equity capital markets.